Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 1/20 | 0.37 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.33 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.32 |
| ▸ | FDPS | P14324 | 4/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.31 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3222075 | 0.98 | ZDHHC7 (0.38) | OPRM1ZDHHC7LMNADNM1SMPD1 | |
| SCHEMBL18691358 | 0.98 | ZDHHC7 (0.38) | OPRM1ZDHHC7LMNADNM1SMPD1 | |
| SCHEMBL3793379 | 0.98 | ZDHHC7 (0.38) | OPRM1ZDHHC7LMNADNM1SMPD1 | |
| SCHEMBL18691419 | 0.98 | ZDHHC7 (0.38) | OPRM1ZDHHC7LMNADNM1SMPD1 | |
| SCHEMBL6703632 | 0.93 | DNM1 (0.35) | DNM1FDPSTSHR | |
| SCHEMBL6703077 | 0.82 | — | — | |
| SCHEMBL26918415 | 0.77 | OPRM1 (0.39) | OPRM1ZDHHC7LMNADNM1SMPD1 | |
| SCHEMBL9693497 | 0.77 | ALDH1A1 (0.33) | TSHR | |
| SCHEMBL5670643 | 0.76 | — | — | |
| SCHEMBL11632706 | 0.70 | DNM1 (0.37) | DNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040076593-A1 | Composition containing a modified nitrocellulose | L'OREAL (FR) | 2004-04-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040076593-A1 | Composition containing a modified nitrocellulose | VCL, C9, LPO | OPRM1 1477/4885ZDHHC7 1167/4885LMNA 660/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.